

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53371123 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.53371123 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.26650105 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.26650105 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.67696071 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.60609085 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37951681 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.30838586 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.17509230 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.02470493 |
| 11 | urea metabolic process (GO:0019627) | 3.99923697 |
| 12 | urea cycle (GO:0000050) | 3.99923697 |
| 13 | cysteine metabolic process (GO:0006534) | 3.95864725 |
| 14 | glyoxylate metabolic process (GO:0046487) | 3.95428258 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 3.91061382 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.91061382 |
| 17 | tryptophan catabolic process (GO:0006569) | 3.91061382 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 3.88637426 |
| 19 | glutamate metabolic process (GO:0006536) | 3.85713424 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 3.83420883 |
| 21 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.78122307 |
| 22 | regulation of ARF protein signal transduction (GO:0032012) | 3.72401472 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 3.70647413 |
| 24 | protein carboxylation (GO:0018214) | 3.68589649 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.68589649 |
| 26 | lysine metabolic process (GO:0006553) | 3.63469449 |
| 27 | lysine catabolic process (GO:0006554) | 3.63469449 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 3.63412271 |
| 29 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.62197827 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 3.61506608 |
| 31 | tryptophan metabolic process (GO:0006568) | 3.61300444 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 3.57470534 |
| 33 | sodium ion export (GO:0071436) | 3.57007599 |
| 34 | bile acid metabolic process (GO:0008206) | 3.55660170 |
| 35 | complement activation, alternative pathway (GO:0006957) | 3.52507779 |
| 36 | protein localization to endosome (GO:0036010) | 3.50521772 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.43641016 |
| 38 | reverse cholesterol transport (GO:0043691) | 3.43475783 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.39613097 |
| 40 | regulation of protein activation cascade (GO:2000257) | 3.38384891 |
| 41 | drug catabolic process (GO:0042737) | 3.37440222 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 3.34845400 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 3.30776765 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.28760446 |
| 45 | synaptic vesicle maturation (GO:0016188) | 3.27012374 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25932739 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 3.25932739 |
| 48 | macromolecular complex remodeling (GO:0034367) | 3.25932739 |
| 49 | cellular modified amino acid catabolic process (GO:0042219) | 3.25925819 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.25690740 |
| 51 | negative regulation of sterol transport (GO:0032372) | 3.23923835 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 3.23923835 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.23644367 |
| 54 | positive regulation of Rap GTPase activity (GO:0032854) | 3.22747769 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.21143679 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.19798969 |
| 57 | gamma-aminobutyric acid transport (GO:0015812) | 3.17618066 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15923053 |
| 59 | regulation of complement activation (GO:0030449) | 3.15506678 |
| 60 | regulation of cholesterol homeostasis (GO:2000188) | 3.14371661 |
| 61 | phospholipid efflux (GO:0033700) | 3.13756758 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.13498540 |
| 63 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.13217268 |
| 64 | acylglycerol homeostasis (GO:0055090) | 3.10615364 |
| 65 | triglyceride homeostasis (GO:0070328) | 3.10615364 |
| 66 | ketone body metabolic process (GO:1902224) | 3.09565845 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 3.09498614 |
| 68 | locomotory exploration behavior (GO:0035641) | 3.09088993 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.08900233 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.08827877 |
| 71 | exogenous drug catabolic process (GO:0042738) | 3.06991756 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 3.06822655 |
| 73 | cholesterol efflux (GO:0033344) | 3.06080902 |
| 74 | drug transmembrane transport (GO:0006855) | 3.05103159 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.02678188 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.01784988 |
| 77 | glutamate secretion (GO:0014047) | 3.01044193 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 2.97051067 |
| 79 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94423961 |
| 80 | cerebellar granule cell differentiation (GO:0021707) | 2.88634921 |
| 81 | bile acid and bile salt transport (GO:0015721) | 2.88543063 |
| 82 | regulation of synaptic vesicle transport (GO:1902803) | 2.87028786 |
| 83 | neurotransmitter secretion (GO:0007269) | 2.85951984 |
| 84 | negative regulation of lipase activity (GO:0060192) | 2.85798389 |
| 85 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.85290236 |
| 86 | dicarboxylic acid catabolic process (GO:0043649) | 2.84956464 |
| 87 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.84068407 |
| 88 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.82332566 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80572021 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.80572021 |
| 91 | positive regulation of fibroblast migration (GO:0010763) | 2.79307602 |
| 92 | synaptic vesicle exocytosis (GO:0016079) | 2.77011280 |
| 93 | L-amino acid import (GO:0043092) | 2.76435425 |
| 94 | ethanol oxidation (GO:0006069) | 2.75094248 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75056452 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 2.74916874 |
| 97 | signal complex assembly (GO:0007172) | 2.74157548 |
| 98 | regulation of Rap GTPase activity (GO:0032317) | 2.73957457 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 2.73897224 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 2.73594375 |
| 101 | regulation of beta-amyloid formation (GO:1902003) | 2.73287381 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 2.73045146 |
| 103 | benzene-containing compound metabolic process (GO:0042537) | 2.72621218 |
| 104 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68718515 |
| 105 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.68104502 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67600535 |
| 107 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.65475301 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 2.64729123 |
| 109 | organic acid catabolic process (GO:0016054) | 2.64729123 |
| 110 | arginine metabolic process (GO:0006525) | 2.64531819 |
| 111 | cholesterol catabolic process (GO:0006707) | 2.64355671 |
| 112 | sterol catabolic process (GO:0016127) | 2.64355671 |
| 113 | cofactor catabolic process (GO:0051187) | 2.62715177 |
| 114 | regulation of extracellular matrix disassembly (GO:0010715) | 2.62238506 |
| 115 | very long-chain fatty acid metabolic process (GO:0000038) | 2.61194543 |
| 116 | low-density lipoprotein particle remodeling (GO:0034374) | 2.60613068 |
| 117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.60419101 |
| 118 | cellular glucuronidation (GO:0052695) | 2.60340687 |
| 119 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.58726128 |
| 120 | layer formation in cerebral cortex (GO:0021819) | 2.58725394 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 2.57475608 |
| 122 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.56881152 |
| 123 | protein-lipid complex assembly (GO:0065005) | 2.56835585 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.56192982 |
| 125 | activation of protein kinase A activity (GO:0034199) | 2.55428635 |
| 126 | positive regulation of protein dephosphorylation (GO:0035307) | 2.54099007 |
| 127 | imidazole-containing compound metabolic process (GO:0052803) | 2.53833165 |
| 128 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.53466791 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52352275 |
| 130 | amino acid import (GO:0043090) | 2.52013681 |
| 131 | potassium ion homeostasis (GO:0055075) | 2.50700737 |
| 132 | regulation of regulated secretory pathway (GO:1903305) | 2.50524389 |
| 133 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.46401650 |
| 134 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.43567607 |
| 135 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.42805526 |
| 136 | regulation of synaptic plasticity (GO:0048167) | 2.39762266 |
| 137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39069691 |
| 138 | positive regulation of synapse maturation (GO:0090129) | 2.38493820 |
| 139 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.34535736 |
| 140 | exploration behavior (GO:0035640) | 2.33894973 |
| 141 | positive regulation of receptor recycling (GO:0001921) | 2.31919881 |
| 142 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.31891981 |
| 143 | regulation of ARF GTPase activity (GO:0032312) | 2.29826462 |
| 144 | potassium ion import (GO:0010107) | 2.28962054 |
| 145 | regulation of leukocyte degranulation (GO:0043300) | 2.28561245 |
| 146 | myelin maintenance (GO:0043217) | 2.26597955 |
| 147 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.25430638 |
| 148 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.25338621 |
| 149 | neuromuscular process controlling balance (GO:0050885) | 2.23089000 |
| 150 | protein targeting to plasma membrane (GO:0072661) | 2.22957235 |
| 151 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.22942111 |
| 152 | positive thymic T cell selection (GO:0045059) | 2.21930086 |
| 153 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.21736543 |
| 154 | dopamine receptor signaling pathway (GO:0007212) | 2.20220792 |
| 155 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.19266471 |
| 156 | mannose metabolic process (GO:0006013) | 2.18717413 |
| 157 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.18411001 |
| 158 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.18148238 |
| 159 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.18114528 |
| 160 | cellular response to monoamine stimulus (GO:0071868) | 2.16061698 |
| 161 | cellular response to catecholamine stimulus (GO:0071870) | 2.16061698 |
| 162 | regulation of cellular amide metabolic process (GO:0034248) | 2.15453209 |
| 163 | neurotransmitter transport (GO:0006836) | 2.14957895 |
| 164 | dendritic spine morphogenesis (GO:0060997) | 2.13633365 |
| 165 | macroautophagy (GO:0016236) | 2.13395367 |
| 166 | barbed-end actin filament capping (GO:0051016) | 2.12063117 |
| 167 | positive regulation of neurotransmitter transport (GO:0051590) | 2.10398843 |
| 168 | regulation of defense response to virus by virus (GO:0050690) | 2.09476008 |
| 169 | long-term synaptic potentiation (GO:0060291) | 2.08254860 |
| 170 | synaptic vesicle endocytosis (GO:0048488) | 2.07192895 |
| 171 | regulation of protein dephosphorylation (GO:0035304) | 2.06854330 |
| 172 | positive regulation of regulated secretory pathway (GO:1903307) | 2.06663225 |
| 173 | mating behavior (GO:0007617) | 2.06333638 |
| 174 | cellular sodium ion homeostasis (GO:0006883) | 2.06121804 |
| 175 | neuronal ion channel clustering (GO:0045161) | 2.05645797 |
| 176 | negative regulation of type 2 immune response (GO:0002829) | 2.05583589 |
| 177 | actin filament capping (GO:0051693) | 2.01969799 |
| 178 | neuromuscular process controlling posture (GO:0050884) | 2.01445446 |
| 179 | regulation of exocytosis (GO:0017157) | 1.99954983 |
| 180 | transferrin transport (GO:0033572) | 1.99255278 |
| 181 | stress fiber assembly (GO:0043149) | 1.98737696 |
| 182 | long-term memory (GO:0007616) | 1.98536714 |
| 183 | macrophage activation involved in immune response (GO:0002281) | 1.98524453 |
| 184 | cell communication by electrical coupling (GO:0010644) | 1.97539817 |
| 185 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 1.95994526 |
| 186 | detection of other organism (GO:0098543) | 1.94785905 |
| 187 | response to catecholamine (GO:0071869) | 1.93824345 |
| 188 | response to monoamine (GO:0071867) | 1.93824345 |
| 189 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.93683741 |
| 190 | dendritic spine organization (GO:0097061) | 1.93151022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.54076930 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.70040558 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92587880 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73496090 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.17156534 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.06369128 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.72052551 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61057069 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.46799892 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33159206 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.10709805 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95656595 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92392425 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92270491 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88013559 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86598732 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85110398 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84744929 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82609492 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.80858865 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79373482 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79298254 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.76461936 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.76287367 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.76211075 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75578032 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74971037 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72978971 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72380645 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72370730 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69745288 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69649578 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60215217 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.55371836 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54016820 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51147942 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49881657 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49881657 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48403704 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47747393 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47408783 |
| 42 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.46004926 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45884056 |
| 44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43989720 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43469336 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41455128 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40949362 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40735870 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38953005 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37102230 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36805667 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34701004 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34215883 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.34097898 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32864144 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32814485 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32576087 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32321374 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28928383 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27723015 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26713839 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26411562 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24721070 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24238030 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24094860 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22023814 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20825255 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.20402866 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19353506 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19300376 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18262477 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18183634 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17902587 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17390684 |
| 75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16759560 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14749728 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14096885 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13356077 |
| 79 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11899302 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11314730 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11233934 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11143457 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09990682 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08566631 |
| 85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05981329 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05191496 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05126208 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03839842 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03616099 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01858938 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01552025 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.01458384 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01281741 |
| 94 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01269290 |
| 95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00636976 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00190625 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99848662 |
| 98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99010962 |
| 99 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98919275 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98715807 |
| 101 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.98095164 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96747259 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96092554 |
| 104 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95288293 |
| 105 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95202738 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95166945 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94959183 |
| 108 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94883172 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94072952 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93848424 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89940550 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89820616 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89347840 |
| 114 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87516001 |
| 115 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86810752 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86113774 |
| 117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85867562 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85519078 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85126109 |
| 120 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83654848 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82143108 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80543759 |
| 123 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77662797 |
| 124 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.75801595 |
| 125 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.72491036 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72371756 |
| 127 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71739236 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71348551 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71274204 |
| 130 | AR_19668381_ChIP-Seq_PC3_Human | 0.71159032 |
| 131 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.70019212 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69893155 |
| 133 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69625540 |
| 134 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69600790 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69476987 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.68275082 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67235354 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67155125 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.66819185 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.66692158 |
| 141 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.66218091 |
| 142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66143548 |
| 143 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65966208 |
| 144 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.65730652 |
| 145 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.65539828 |
| 146 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.65348514 |
| 147 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64510488 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.64441042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.10358834 |
| 2 | MP0005360_urolithiasis | 5.34026655 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.47950611 |
| 4 | MP0005365_abnormal_bile_salt | 4.39314457 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.71552849 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.70112585 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.83310210 |
| 8 | MP0003252_abnormal_bile_duct | 2.71639936 |
| 9 | MP0005083_abnormal_biliary_tract | 2.54113863 |
| 10 | MP0003195_calcinosis | 2.52506297 |
| 11 | MP0009840_abnormal_foam_cell | 2.37766205 |
| 12 | MP0003329_amyloid_beta_deposits | 2.31162386 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.29841854 |
| 14 | MP0003303_peritoneal_inflammation | 2.27792678 |
| 15 | MP0002822_catalepsy | 2.17444321 |
| 16 | MP0005409_darkened_coat_color | 2.08910178 |
| 17 | MP0005332_abnormal_amino_acid | 2.07757536 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.04459600 |
| 19 | MP0001666_abnormal_nutrient_absorption | 1.96237017 |
| 20 | MP0004270_analgesia | 1.88743293 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.87049348 |
| 22 | MP0003880_abnormal_central_pattern | 1.86336675 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.85811761 |
| 24 | MP0008260_abnormal_autophagy | 1.85391430 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.83258652 |
| 26 | MP0009745_abnormal_behavioral_response | 1.83224719 |
| 27 | MP0000604_amyloidosis | 1.82122401 |
| 28 | MP0002064_seizures | 1.82090532 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.80148552 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.79618689 |
| 31 | MP0003436_decreased_susceptibility_to | 1.73516039 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.73443768 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.67548979 |
| 34 | MP0009046_muscle_twitch | 1.57008788 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54173646 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.50081701 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.49711226 |
| 38 | MP0001958_emphysema | 1.48878690 |
| 39 | MP0003868_abnormal_feces_composition | 1.48743357 |
| 40 | MP0004043_abnormal_pH_regulation | 1.48022414 |
| 41 | MP0000609_abnormal_liver_physiology | 1.47710100 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.45674958 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.44512819 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.41686413 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.41586474 |
| 46 | MP0002272_abnormal_nervous_system | 1.37166656 |
| 47 | MP0003634_abnormal_glial_cell | 1.36874749 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.35057925 |
| 49 | MP0003690_abnormal_glial_cell | 1.33041018 |
| 50 | MP0005535_abnormal_body_temperature | 1.32705793 |
| 51 | MP0003724_increased_susceptibility_to | 1.31914010 |
| 52 | MP0003879_abnormal_hair_cell | 1.28466338 |
| 53 | MP0004381_abnormal_hair_follicle | 1.25115743 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.24838009 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.22513815 |
| 56 | MP0003075_altered_response_to | 1.21933758 |
| 57 | MP0004858_abnormal_nervous_system | 1.19531938 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.17968894 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.17907546 |
| 60 | MP0003045_fibrosis | 1.17689367 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.16448115 |
| 62 | MP0003633_abnormal_nervous_system | 1.16281142 |
| 63 | MP0002419_abnormal_innate_immunity | 1.16076993 |
| 64 | MP0001486_abnormal_startle_reflex | 1.14532886 |
| 65 | MP0003123_paternal_imprinting | 1.12812547 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.11722881 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.11704342 |
| 68 | MP0003866_abnormal_defecation | 1.11643432 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.10689050 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.09707940 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 1.08840621 |
| 72 | MP0000685_abnormal_immune_system | 1.08801438 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.07558912 |
| 74 | MP0004885_abnormal_endolymph | 1.06896819 |
| 75 | MP0002736_abnormal_nociception_after | 1.06557868 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.06295656 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.05704577 |
| 78 | MP0001984_abnormal_olfaction | 1.05625933 |
| 79 | MP0005025_abnormal_response_to | 1.04552474 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.04317466 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.04237373 |
| 82 | MP0004947_skin_inflammation | 1.02249235 |
| 83 | MP0008569_lethality_at_weaning | 1.02141290 |
| 84 | MP0009643_abnormal_urine_homeostasis | 1.01973551 |
| 85 | MP0008874_decreased_physiological_sensi | 1.01546642 |
| 86 | MP0004130_abnormal_muscle_cell | 1.00499527 |
| 87 | MP0009278_abnormal_bone_marrow | 0.99833294 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 0.99058969 |
| 89 | MP0008872_abnormal_physiological_respon | 0.98782484 |
| 90 | MP0002090_abnormal_vision | 0.97063206 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.96511855 |
| 92 | MP0001764_abnormal_homeostasis | 0.94772899 |
| 93 | MP0003632_abnormal_nervous_system | 0.94669559 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.94369820 |
| 95 | MP0001849_ear_inflammation | 0.93824689 |
| 96 | MP0005000_abnormal_immune_tolerance | 0.93587765 |
| 97 | MP0003122_maternal_imprinting | 0.93018149 |
| 98 | MP0002735_abnormal_chemical_nociception | 0.92912762 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.92683306 |
| 100 | MP0001851_eye_inflammation | 0.89322348 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.88959820 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.88706163 |
| 103 | MP0002067_abnormal_sensory_capabilities | 0.88516874 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.88330751 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.88160988 |
| 106 | MP0001970_abnormal_pain_threshold | 0.87939319 |
| 107 | MP0004811_abnormal_neuron_physiology | 0.87770564 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.87569183 |
| 109 | MP0002229_neurodegeneration | 0.86795865 |
| 110 | MP0003091_abnormal_cell_migration | 0.86734307 |
| 111 | MP0003631_nervous_system_phenotype | 0.86191454 |
| 112 | MP0002557_abnormal_social/conspecific_i | 0.83084838 |
| 113 | MP0001790_abnormal_immune_system | 0.82857552 |
| 114 | MP0005387_immune_system_phenotype | 0.82857552 |
| 115 | MP0001905_abnormal_dopamine_level | 0.82380049 |
| 116 | MP0001835_abnormal_antigen_presentation | 0.81673225 |
| 117 | MP0006082_CNS_inflammation | 0.80550596 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.79885151 |
| 119 | MP0000955_abnormal_spinal_cord | 0.79533450 |
| 120 | MP0000920_abnormal_myelination | 0.79512701 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.79050317 |
| 122 | MP0005448_abnormal_energy_balance | 0.78850602 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.78452814 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.76916476 |
| 125 | MP0004924_abnormal_behavior | 0.75151436 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.75151436 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.74985951 |
| 128 | MP0003787_abnormal_imprinting | 0.74519754 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.73907438 |
| 130 | MP0003953_abnormal_hormone_level | 0.73711782 |
| 131 | MP0003279_aneurysm | 0.72230071 |
| 132 | MP0002420_abnormal_adaptive_immunity | 0.72183029 |
| 133 | MP0004510_myositis | 0.71583843 |
| 134 | MP0005410_abnormal_fertilization | 0.70552757 |
| 135 | MP0001756_abnormal_urination | 0.70416932 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.70099467 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.70031520 |
| 138 | MP0001819_abnormal_immune_cell | 0.69892519 |
| 139 | MP0003011_delayed_dark_adaptation | 0.69615395 |
| 140 | MP0005451_abnormal_body_composition | 0.66335589 |
| 141 | MP0005166_decreased_susceptibility_to | 0.64169763 |
| 142 | MP0005076_abnormal_cell_differentiation | 0.62859383 |
| 143 | MP0004142_abnormal_muscle_tone | 0.62714270 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.62503352 |
| 145 | MP0000598_abnormal_liver_morphology | 0.61841775 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.61819643 |
| 147 | MP0005334_abnormal_fat_pad | 0.61593268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.55023555 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.24186624 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.65454572 |
| 4 | Xanthomatosis (HP:0000991) | 4.43351619 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.18772359 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.03455534 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.00538669 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.80916380 |
| 9 | Complement deficiency (HP:0004431) | 3.70647008 |
| 10 | Myokymia (HP:0002411) | 3.64405690 |
| 11 | Ketosis (HP:0001946) | 3.60443206 |
| 12 | Abnormality of binocular vision (HP:0011514) | 3.37053515 |
| 13 | Diplopia (HP:0000651) | 3.37053515 |
| 14 | Obstructive sleep apnea (HP:0002870) | 3.32115646 |
| 15 | Visual hallucinations (HP:0002367) | 3.13649779 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.06763213 |
| 17 | Hyperammonemia (HP:0001987) | 3.05733909 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.04661761 |
| 19 | Gout (HP:0001997) | 2.98458037 |
| 20 | Ketoacidosis (HP:0001993) | 2.94615506 |
| 21 | Epidermoid cyst (HP:0200040) | 2.93221398 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.91878704 |
| 23 | Hyperglycinemia (HP:0002154) | 2.91577725 |
| 24 | Focal motor seizures (HP:0011153) | 2.91311685 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.89777309 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.89072074 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 2.85640517 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84524521 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84524521 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84524521 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.82152939 |
| 32 | Cholecystitis (HP:0001082) | 2.80709895 |
| 33 | Abnormal gallbladder physiology (HP:0012438) | 2.80709895 |
| 34 | Status epilepticus (HP:0002133) | 2.79333279 |
| 35 | Joint hemorrhage (HP:0005261) | 2.73844576 |
| 36 | Abnormality of the lower motor neuron (HP:0002366) | 2.72591165 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.72237255 |
| 38 | Hyperbilirubinemia (HP:0002904) | 2.70868454 |
| 39 | Delayed CNS myelination (HP:0002188) | 2.61449693 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61088287 |
| 41 | Fat malabsorption (HP:0002630) | 2.59075376 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58262274 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.58262274 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58133722 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55677376 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.55677376 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.55262407 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.55087404 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52889990 |
| 50 | Abnormality of complement system (HP:0005339) | 2.52792187 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52460014 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52460014 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52460014 |
| 54 | Focal seizures (HP:0007359) | 2.48158069 |
| 55 | Torticollis (HP:0000473) | 2.46549024 |
| 56 | Papilledema (HP:0001085) | 2.46092974 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.44920898 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.41195758 |
| 59 | Hyperglycinuria (HP:0003108) | 2.41181544 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.40959206 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.39766043 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37990771 |
| 63 | Focal dystonia (HP:0004373) | 2.37505499 |
| 64 | Postural instability (HP:0002172) | 2.36249814 |
| 65 | Ocular albinism (HP:0001107) | 2.35809860 |
| 66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.35165881 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.35003468 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.34063182 |
| 69 | Global brain atrophy (HP:0002283) | 2.33642485 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.33294003 |
| 71 | Craniofacial dystonia (HP:0012179) | 2.33174051 |
| 72 | Slow saccadic eye movements (HP:0000514) | 2.31173508 |
| 73 | Cholelithiasis (HP:0001081) | 2.29337256 |
| 74 | Sensorimotor neuropathy (HP:0007141) | 2.27457918 |
| 75 | Abnormality of the Achilles tendon (HP:0005109) | 2.27416936 |
| 76 | Abnormality of purine metabolism (HP:0004352) | 2.26344246 |
| 77 | Amyloidosis (HP:0011034) | 2.24909978 |
| 78 | Action tremor (HP:0002345) | 2.24496966 |
| 79 | Neonatal onset (HP:0003623) | 2.23273260 |
| 80 | Hypercortisolism (HP:0001578) | 2.22053328 |
| 81 | Abnormality of methionine metabolism (HP:0010901) | 2.20866867 |
| 82 | Depression (HP:0000716) | 2.19831965 |
| 83 | Irritability (HP:0000737) | 2.18983181 |
| 84 | Acanthocytosis (HP:0001927) | 2.18497437 |
| 85 | Abnormal social behavior (HP:0012433) | 2.17980712 |
| 86 | Impaired social interactions (HP:0000735) | 2.17980712 |
| 87 | Generalized tonic-clonic seizures (HP:0002069) | 2.17304327 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.14907817 |
| 89 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14399587 |
| 90 | Purpura (HP:0000979) | 2.14195472 |
| 91 | Intention tremor (HP:0002080) | 2.11856220 |
| 92 | Akinesia (HP:0002304) | 2.11845262 |
| 93 | Hyperparathyroidism (HP:0000843) | 2.11729843 |
| 94 | Skin nodule (HP:0200036) | 2.10743152 |
| 95 | Annular pancreas (HP:0001734) | 2.10402009 |
| 96 | Hyperventilation (HP:0002883) | 2.09443475 |
| 97 | Growth hormone excess (HP:0000845) | 2.09374975 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.09340376 |
| 99 | Protrusio acetabuli (HP:0003179) | 2.07994700 |
| 100 | Anxiety (HP:0000739) | 2.06039569 |
| 101 | Mutism (HP:0002300) | 2.05666385 |
| 102 | Tetraplegia (HP:0002445) | 2.05146420 |
| 103 | Abnormal eating behavior (HP:0100738) | 2.04780953 |
| 104 | Loss of speech (HP:0002371) | 2.03200791 |
| 105 | Late onset (HP:0003584) | 2.02086181 |
| 106 | Rigidity (HP:0002063) | 2.01326162 |
| 107 | Cellulitis (HP:0100658) | 2.00330265 |
| 108 | Death in childhood (HP:0003819) | 2.00101859 |
| 109 | Absence seizures (HP:0002121) | 1.99940973 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99403886 |
| 111 | Poikilocytosis (HP:0004447) | 1.99003343 |
| 112 | Peripheral hypomyelination (HP:0007182) | 1.98972541 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 1.98645387 |
| 114 | Apathy (HP:0000741) | 1.98501824 |
| 115 | Iris hypopigmentation (HP:0007730) | 1.97815112 |
| 116 | Poor eye contact (HP:0000817) | 1.97664964 |
| 117 | Abnormality of nucleobase metabolism (HP:0010932) | 1.96126587 |
| 118 | Spastic tetraparesis (HP:0001285) | 1.95921305 |
| 119 | Alkalosis (HP:0001948) | 1.95052669 |
| 120 | Dysdiadochokinesis (HP:0002075) | 1.94974845 |
| 121 | Diminished motivation (HP:0000745) | 1.94296078 |
| 122 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93418984 |
| 123 | Metabolic acidosis (HP:0001942) | 1.92984301 |
| 124 | Spontaneous abortion (HP:0005268) | 1.92930293 |
| 125 | Mitral stenosis (HP:0001718) | 1.92594723 |
| 126 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.90410482 |
| 127 | Reticulocytosis (HP:0001923) | 1.90329752 |
| 128 | Dysmetria (HP:0001310) | 1.89324050 |
| 129 | Testicular neoplasm (HP:0010788) | 1.88636758 |
| 130 | Turricephaly (HP:0000262) | 1.88390009 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87363904 |
| 132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84836084 |
| 133 | Brushfield spots (HP:0001088) | 1.84545512 |
| 134 | Gingival bleeding (HP:0000225) | 1.84301998 |
| 135 | Abnormality of the gallbladder (HP:0005264) | 1.84262929 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84126466 |
| 137 | Arterial tortuosity (HP:0005116) | 1.83329759 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.83046402 |
| 139 | Truncal ataxia (HP:0002078) | 1.82508254 |
| 140 | Confusion (HP:0001289) | 1.82169187 |
| 141 | Insomnia (HP:0100785) | 1.81563350 |
| 142 | Spastic gait (HP:0002064) | 1.81297416 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.81261175 |
| 144 | Steatorrhea (HP:0002570) | 1.80549634 |
| 145 | Agitation (HP:0000713) | 1.80512923 |
| 146 | Rapidly progressive (HP:0003678) | 1.80161393 |
| 147 | Progressive cerebellar ataxia (HP:0002073) | 1.79706233 |
| 148 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79334082 |
| 149 | Obstructive lung disease (HP:0006536) | 1.79334082 |
| 150 | Ankle clonus (HP:0011448) | 1.78624635 |
| 151 | Vascular tortuosity (HP:0004948) | 1.77604032 |
| 152 | Myositis (HP:0100614) | 1.77302158 |
| 153 | Epileptic encephalopathy (HP:0200134) | 1.76810567 |
| 154 | Systemic lupus erythematosus (HP:0002725) | 1.76473432 |
| 155 | Upper limb amyotrophy (HP:0009129) | 1.76308577 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.76308577 |
| 157 | Recurrent bacterial skin infections (HP:0005406) | 1.76298632 |
| 158 | Dementia (HP:0000726) | 1.75364087 |
| 159 | Gastrointestinal infarctions (HP:0005244) | 1.74144164 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.73497808 |
| 161 | Macroorchidism (HP:0000053) | 1.73229030 |
| 162 | Increased IgE level (HP:0003212) | 1.73103233 |
| 163 | Decreased motor nerve conduction velocity (HP:0003431) | 1.72252720 |
| 164 | Hemiplegia (HP:0002301) | 1.71743543 |
| 165 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70928499 |
| 166 | Spinal canal stenosis (HP:0003416) | 1.70073279 |
| 167 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69428422 |
| 168 | Gingivitis (HP:0000230) | 1.69401371 |
| 169 | Polygenic inheritance (HP:0010982) | 1.66352302 |
| 170 | Orchitis (HP:0100796) | 1.65887189 |
| 171 | Episodic fever (HP:0001954) | 1.65822327 |
| 172 | Nuclear cataract (HP:0100018) | 1.62516214 |
| 173 | Hyperacusis (HP:0010780) | 1.62460405 |
| 174 | Bradykinesia (HP:0002067) | 1.61758679 |
| 175 | Interstitial pulmonary disease (HP:0006530) | 1.61243938 |
| 176 | Increased CSF protein (HP:0002922) | 1.60238635 |
| 177 | Abnormality of saccadic eye movements (HP:0000570) | 1.60155430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.25092661 |
| 2 | DAPK2 | 3.01900281 |
| 3 | PRPF4B | 3.00179414 |
| 4 | NTRK3 | 2.99546709 |
| 5 | MAP3K9 | 2.82596372 |
| 6 | KSR2 | 2.40000770 |
| 7 | PRKD3 | 2.30566994 |
| 8 | TRIB3 | 2.29443089 |
| 9 | CAMKK1 | 2.25839570 |
| 10 | MAP2K4 | 2.24654753 |
| 11 | BCKDK | 2.20059612 |
| 12 | ERN1 | 1.98011749 |
| 13 | MAP3K4 | 1.96558831 |
| 14 | MARK1 | 1.92418033 |
| 15 | INSRR | 1.88816958 |
| 16 | MAP3K2 | 1.83515486 |
| 17 | MINK1 | 1.81327380 |
| 18 | NTRK1 | 1.80151730 |
| 19 | SIK1 | 1.75623717 |
| 20 | PAK6 | 1.74686191 |
| 21 | EPHB1 | 1.67184632 |
| 22 | MAP3K11 | 1.52629897 |
| 23 | NTRK2 | 1.48514930 |
| 24 | SMG1 | 1.47444892 |
| 25 | SIK2 | 1.46173822 |
| 26 | MAP2K3 | 1.45229431 |
| 27 | RIPK4 | 1.37714800 |
| 28 | MAP3K3 | 1.36468004 |
| 29 | PKN2 | 1.35242929 |
| 30 | RIPK1 | 1.34667584 |
| 31 | STK38 | 1.30460965 |
| 32 | TAOK1 | 1.27062364 |
| 33 | CDK5 | 1.25161118 |
| 34 | MAP2K7 | 1.23374206 |
| 35 | FGFR4 | 1.22767053 |
| 36 | PRKD2 | 1.21665462 |
| 37 | RET | 1.21521196 |
| 38 | PRKCH | 1.21476904 |
| 39 | TAOK3 | 1.20365002 |
| 40 | DAPK1 | 1.16458871 |
| 41 | CAMKK2 | 1.16375564 |
| 42 | MAP4K1 | 1.15298359 |
| 43 | PINK1 | 1.15150472 |
| 44 | MAP3K13 | 1.11118236 |
| 45 | PRKCG | 1.10939309 |
| 46 | HIPK2 | 1.07639454 |
| 47 | GRK5 | 1.06770981 |
| 48 | SCYL2 | 1.05762781 |
| 49 | TESK1 | 1.05719117 |
| 50 | PDPK1 | 1.05409404 |
| 51 | ICK | 1.05378769 |
| 52 | TYK2 | 1.03368569 |
| 53 | MAP3K7 | 1.02682297 |
| 54 | JAK1 | 1.01756542 |
| 55 | MAP3K1 | 1.00025709 |
| 56 | FGFR3 | 0.99025032 |
| 57 | PDK1 | 0.98071532 |
| 58 | ZAP70 | 0.97885374 |
| 59 | CAMK1G | 0.97296116 |
| 60 | CDK19 | 0.96298645 |
| 61 | ARAF | 0.93582447 |
| 62 | SGK494 | 0.92971647 |
| 63 | SGK223 | 0.92971647 |
| 64 | BLK | 0.91062630 |
| 65 | KSR1 | 0.90829242 |
| 66 | WNK4 | 0.90420808 |
| 67 | PRKCZ | 0.89633191 |
| 68 | TYRO3 | 0.87390857 |
| 69 | FES | 0.85566330 |
| 70 | OXSR1 | 0.84858034 |
| 71 | MARK2 | 0.83889827 |
| 72 | CSNK1G2 | 0.81801099 |
| 73 | JAK2 | 0.81076131 |
| 74 | SGK3 | 0.80980512 |
| 75 | STK11 | 0.80573944 |
| 76 | CAMK1 | 0.79720775 |
| 77 | UHMK1 | 0.76880891 |
| 78 | EEF2K | 0.73836724 |
| 79 | IRAK3 | 0.73093469 |
| 80 | TAOK2 | 0.72644899 |
| 81 | GRK6 | 0.71865305 |
| 82 | PTK6 | 0.71698093 |
| 83 | MAPK15 | 0.69442845 |
| 84 | TNIK | 0.68369217 |
| 85 | PDGFRA | 0.66942434 |
| 86 | IRAK2 | 0.65245734 |
| 87 | MAP2K2 | 0.64965727 |
| 88 | NEK6 | 0.64792013 |
| 89 | MAPK11 | 0.63437984 |
| 90 | WNK3 | 0.62688786 |
| 91 | PTK2 | 0.61216234 |
| 92 | CAMK2G | 0.61203945 |
| 93 | CSK | 0.60880012 |
| 94 | PRKG2 | 0.60014932 |
| 95 | MAP2K1 | 0.59724864 |
| 96 | MAP3K12 | 0.59561008 |
| 97 | DYRK1B | 0.59536355 |
| 98 | PTK2B | 0.59427840 |
| 99 | ALK | 0.58748878 |
| 100 | CAMK2A | 0.58495102 |
| 101 | CAMK2B | 0.57681898 |
| 102 | MAPK12 | 0.57261773 |
| 103 | FYN | 0.57164600 |
| 104 | PRKACG | 0.55965936 |
| 105 | PAK3 | 0.55825666 |
| 106 | HCK | 0.55800768 |
| 107 | TBK1 | 0.55622216 |
| 108 | IRAK4 | 0.55567987 |
| 109 | BRAF | 0.55532873 |
| 110 | CDK15 | 0.55283385 |
| 111 | SYK | 0.55012787 |
| 112 | LATS2 | 0.54582573 |
| 113 | ROCK2 | 0.54333083 |
| 114 | CDC42BPA | 0.54128633 |
| 115 | PHKG1 | 0.53138876 |
| 116 | PHKG2 | 0.53138876 |
| 117 | FGFR2 | 0.50050976 |
| 118 | CAMK4 | 0.49984108 |
| 119 | CDK18 | 0.49105957 |
| 120 | CDK14 | 0.48774739 |
| 121 | CAMK1D | 0.48462350 |
| 122 | ABL2 | 0.47944630 |
| 123 | BMX | 0.47815438 |
| 124 | PRKAA1 | 0.47562657 |
| 125 | LMTK2 | 0.47550112 |
| 126 | RAF1 | 0.47176880 |
| 127 | EPHA2 | 0.46870822 |
| 128 | BMPR2 | 0.46761372 |
| 129 | CDK11A | 0.46593099 |
| 130 | RPS6KA2 | 0.46341710 |
| 131 | SGK2 | 0.45811485 |
| 132 | MST1R | 0.45739788 |
| 133 | TNK2 | 0.45680158 |
| 134 | RPS6KA3 | 0.45640244 |
| 135 | SGK1 | 0.44920893 |
| 136 | DAPK3 | 0.44791326 |
| 137 | MAP2K6 | 0.44684576 |
| 138 | PRKD1 | 0.42481138 |
| 139 | WNK1 | 0.42114663 |
| 140 | LRRK2 | 0.40812017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.93311106 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.50284607 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02742537 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74116022 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.55305187 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18095216 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14689421 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97821325 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95533252 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92318504 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.90542743 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84718680 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76196656 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70016850 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.68512787 |
| 16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68003767 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61501329 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54253910 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50557734 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46699522 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44714349 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42840181 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42406449 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.39028255 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38894661 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36537324 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36254456 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35358205 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33606166 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31321511 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31073539 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.30547036 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29771620 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26263206 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26100962 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25073025 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24866846 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24595680 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20428888 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20076837 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20002860 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.18801506 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18255895 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16599640 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.16080783 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15805190 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15617120 |
| 48 | Nicotine addiction_Homo sapiens_hsa05033 | 1.14988837 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14271514 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12437775 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12292681 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12263003 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.10826521 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10156222 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.07903086 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07048809 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06607856 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05253321 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03203362 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 1.01225467 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00184710 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99927945 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99407095 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.99220392 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98898771 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98247796 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96185608 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96085231 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95989090 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95191485 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92580890 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92566907 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91909304 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91711080 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91233806 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89081800 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88262101 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88047221 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87998352 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86865198 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86494238 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.86426369 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86293542 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85461412 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84952155 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84612019 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84452057 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.84268788 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83860063 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83572638 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83572432 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83250698 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.82700890 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81478153 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80621428 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80223297 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.78895108 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78634817 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78497358 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78240213 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76270860 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75960378 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75243896 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75170518 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.74694087 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74541944 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74484763 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73836311 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73340188 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73194692 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73015283 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72713991 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72706550 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72695382 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72502707 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72048209 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71877538 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71768128 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71468448 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70644897 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69834825 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68350996 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66642207 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65667051 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64988991 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64843861 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.64774407 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64321950 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63695089 |
| 130 | Melanogenesis_Homo sapiens_hsa04916 | 0.63529526 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.62321986 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62172677 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61859090 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.61772342 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61217585 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59878040 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59056165 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58411417 |
| 139 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58340616 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56815291 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56589701 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.56254330 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.56169004 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55165710 |
| 145 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54279649 |
| 146 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53858114 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53317514 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51145609 |
| 149 | Taste transduction_Homo sapiens_hsa04742 | 0.50390872 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50105972 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48543799 |
| 152 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48330991 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46559327 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45882510 |
| 155 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43952923 |
| 156 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42512388 |
| 157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41700926 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.38643631 |
| 159 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38453034 |
| 160 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37531311 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.37215780 |
| 162 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37211937 |
| 163 | Long-term depression_Homo sapiens_hsa04730 | 0.35050213 |
| 164 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34412831 |

